Gsk (GLAXF) Change in Taxes (2009 - 2026)

Gsk's Change in Taxes history runs 18 years deep, the most recent figure standing at $411.2 million for Q1 2026.

• In Q1 2026, Change in Taxes fell 2.84% year-over-year to $411.2 million; the TTM figure through Mar 2026 stood at $1.7 billion (down 14.06% YoY), while the FY2025 annual figure was $1.5 billion, up 118.06% from the prior year.
• Change in Taxes was $411.2 million for Q1 2026 at Gsk, up from $296.6 million in the prior quarter.
• In the past five years, Change in Taxes ranged from a high of $642.9 million in Q4 2023 to a low of $296.6 million in Q4 2025.
• Historically, Change in Taxes has averaged $449.1 million across 5 years, with a median of $423.2 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Change in Taxes jumped 994.71% in 2022, then slumped 50.3% in 2025.
• A 5-year view of Change in Taxes shows it stood at $554.8 million in 2022, then increased by 15.88% to $642.9 million in 2023, then fell by 7.17% to $596.8 million in 2024, then sank by 50.3% to $296.6 million in 2025, then surged by 38.62% to $411.2 million in 2026.
• The last three Change in Taxes figures came in at $411.2 million (Q1 2026), $296.6 million (Q4 2025), and $423.2 million (Q1 2025), per Business Quant data.